Article
Leukemias related to treatment with DNA topoisomerase II inhibitors*
13 Apr 2001
Abstract excerpt
The epipodophyllotoxins etoposide and teniposide and other DNA topoisomerase II inhibitors including anthracyclines and dactinomycin are highly efficacious anticancer drugs. All are associated with a distinct form of leukemia characterized by chromosomal translocations as a treatment complication. Most of the translocations disrupt a breakpoint cluster region (bcr) of the MLL gene at chromosome band 11q23. Other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
